Status:

RECRUITING

Dose Escalation Using Hypoxia-adjusted Radiotherapy

Lead Sponsor:

Rajiv Gandhi Cancer Institute & Research Center, India

Collaborating Sponsors:

Varian, a Siemens Healthineers Company

Conditions:

Head and Neck Squamous Cell Carcinoma

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

DE-HyART is a phase II clinical trial aimed at understanding the effects of escalating radiation doses to hypoxic sub-volumes inherent to squamous cell head and neck cancer. The study is aimed at asse...

Detailed Description

DE-HyART is a randomized, non-blinded study that assesses the effects of combining IMRT (using SIB-Sequential planning) with dose-escalation to hypoxic sub-volume delineated using \[18-F\] FMISO. The ...

Eligibility Criteria

Inclusion

  • Age: 18 - 70 years
  • Willingness to sign informed consent (written/video documentation)
  • Performance status: ECOG 0 - 2
  • Histology proved - squamous cell carcinoma
  • Any grade, gender
  • Tumour sites: Oral Cavity, Oropharynx, Hypopharynx and Larynx
  • Sufficient bone marrow reserve within the last 14 days.
  • Hb: \> 10g/dl (corrected)
  • TLC: \> 4,000 per cumm
  • Platelet: \>1.5Lakh per cumm
  • Liver functions and kidney functions within normal limits
  • Nutritional and dental assessment before inclusion into the study

Exclusion

  • HPV (p16) positive tumours
  • Prior surgery and/or radiation therapy given for any HNC
  • T1/T2 Glottis
  • Metastatic disease or disease not amenable for definitive locoregional treatment.
  • Medical co-morbidity hampering the administration of radiation and/or chemotherapy (cisplatin)
  • Pregnancy or lactation

Key Trial Info

Start Date :

April 8 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2028

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT06087614

Start Date

April 8 2024

End Date

April 1 2028

Last Update

January 17 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rajiv Gandhi Cancer Institute and Research Centre

Delhi, India, 110085